Literature DB >> 11725931

Testing dose-response relationships with a priori unknown, possibly nonmonotone shapes.

F Bretz1, L A Hothorn.   

Abstract

Usually, a monotone dose-response dependence can be assumed for the simultaneous comparison of increasing levels of a certain drug. However, sometimes a reversal of the dose-response curve is likely to occur at the higher doses. We investigate such violations of the monotonicity assumption. Adequate alternatives are discussed and the "protected trend alternative" is introduced. Together with the umbrella patterns described in the literature, we introduce new testing approaches for both alternatives. P-values/quantiles and power values/sample sizes are made numerically available and hence are readily computed. A short power study and the analysis of a data set from the literature demonstrate the improved behavior of the new methods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725931     DOI: 10.1081/BIP-100107657

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.

Authors:  Hélène Meistermann; Junjun Gao; Sabrina Golling; Jens Lamerz; Sophie Le Pogam; Manuel Tzouros; Sailaja Sankabathula; Lore Gruenbaum; Isabel Nájera; Hanno Langen; Klaus Klumpp; Angélique Augustin
Journal:  Mol Cell Proteomics       Date:  2014-07-20       Impact factor: 5.911

2.  Statistical power considerations show the endocrine disruptor low-dose issue in a new light.

Authors:  Martin Scholze; Andreas Kortenkamp
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

3.  Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.

Authors:  Manaswini Sivaramakrishnan; Kathleen D McCarthy; Sébastien Campagne; Sylwia Huber; Sonja Meier; Angélique Augustin; Tobias Heckel; Hélène Meistermann; Melanie N Hug; Pascale Birrer; Ahmed Moursy; Sarah Khawaja; Roland Schmucki; Nikos Berntenis; Nicolas Giroud; Sabrina Golling; Manuel Tzouros; Balazs Banfai; Gonzalo Duran-Pacheco; Jens Lamerz; Ying Hsiu Liu; Thomas Luebbers; Hasane Ratni; Martin Ebeling; Antoine Cléry; Sergey Paushkin; Adrian R Krainer; Frédéric H-T Allain; Friedrich Metzger
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.